(Q77980859)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10399328%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

title

Production of highly purified clotting factor IX by a combination of different chromatographic methods (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10399328%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

author name string

L Hoffer

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10399328%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

H Schwinn

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10399328%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

D Josić

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10399328%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

publication date

1 June 1999

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10399328%20AND%20SRC:MED&resulttype=core&format=json

Journal of Chromatography

9 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10399328%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

volume

844

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10399328%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

issue

1-2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10399328%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

page(s)

119-128

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10399328%20AND%20SRC:MED&resulttype=core&format=json

The coagulation cascade: initiation, maintenance, and regulation

9 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2899%2900348-9

A comparison of human prothrombin, factor IX (Christmas factor), factor X (Stuart factor), and protein S

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2899%2900348-9

Human coagulation factor IX. Isolation and characterization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2899%2900348-9

High-performance capillary electrophoresis for in-process control in the production of antithrombin III and human clotting factor IX

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2899%2900348-9

Recent evolution of clotting factor concentrates for hemophilia A and B. Transfusion Practices Committee

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2899%2900348-9

HIGH-POTENCY ANTIHAEMOPHILIC FACTOR CONCENTRATE PREPARED FROM CRYOGLOBULIN PRECIPITATE.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2899%2900348-9

No activation of the common pathway of the coagulation cascade after a highly purified factor IX concentrate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2899%2900348-9

Properties of a highly purified human plasma factor IX:c therapeutic concentrate prepared by conventional chromatography

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2899%2900348-9

Improved virus safety and purity of a chromatographically produced Factor IX concentrate by nanofiltration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2899%2900348-9

Factor IX concentrate versus prothrombin complex concentrate for the treatment of hemophilia B during surgery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2899%2900348-9

High resolution removal of virus from protein solutions using a membrane of unique structure

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2899%2900348-9

Value of virus filtration as a method for improving the safety of plasma products

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2899%2900348-9

Nanofiltration, a new specific virus elimination method applied to high-purity factor IX and factor XI concentrates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2899%2900348-9

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2899%2900348-9

Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2899%2900348-9

Factor VII and activated-factor-VII content of prothrombin complex concentrates. The PCC Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0021-9673%2899%2900348-9

10.1016/S0021-9673(99)00348-9

7 January 2021

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10399328%20AND%20SRC:MED&resulttype=core&format=json

9 December 2019

1 reference